Back
Open Access

Added value of therapy with sucrosomial iron (SI) on top on ferricarboxymaltose (FCM) for the treatment of iron deficiency anemia (IDA) after cardiac surgery (CS): preliminary data

Session: Assessing and managing cardiovascular risk after interventions and surgery
Topic: Cardiovascular Rehabilitation
Speaker: Doctor E. Venturini (Cecina, IT)
Event: ESC Preventive Cardiology 2024

Congress Presentation

Add to my library

Like

About the speaker

Doctor Elio Venturini

Civil Hospital Cecina, Cecina (Italy)
2 presentations
0 follower

9 more presentations in this session

Efficacy of early versus late b-blocker administration after primary PCI

Speaker: Doctor M. Kondylis (Athens, GR)

Access
Abstract
Slides
Like
Thumbnail

Cardiac rehabilitation improves subclinical left ventricular dysfunction in patients after cardiac surgery

Speaker: Doctor F. Perone (Castel Morrone, IT)

Access
Abstract
Slides
Like
Thumbnail

Analyzing aortic stenosis-related mortality before and after transcatheter aortic valve replacement approval: insights from CDC data

Speaker: Mr S. Ashri (Tel Aviv, IL)

Access
Abstract
Slides
Like
Thumbnail

Smart assistance for coronary artery disease patients with low ejection fraction and dilated cardiomyopathy treated with percutaneous coronary intervention: preliminary results from SCAD pilot study

Speaker: Doctor E. Elia (Alessandria, IT)

Access
Abstract
Slides
Like
Thumbnail

The impact of extracorporeal membrane oxygenation on mortality in patients with cardiogenic shock post acute myocardial infarction: a systematic review and meta-analysis

Speaker: Doctor S. Paddock (Norfolk, GB)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Assessing and managing cardiovascular risk after interventions and surgery

Speakers: Doctor E. Venturini, Doctor M. Kondylis, Doctor F. Perone, Mr S. Ashri, Doctor E. Elia...
Access
Like
Thumbnail

About the event

Image

ESC Preventive Cardiology 2024

25 April - 27 April 2024

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources